Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetaminophen + ibuprofen is an oral fixed-dose combination of two well-known analgesics used for the short-term management of mild to moderate pain. Acetaminophen (also known as paracetamol) acts primarily as a central analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic, antipyretic, and anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing prostaglandin synthesis peripherally. The combination leverages complementary mechanisms for enhanced pain relief compared to either agent alone. It is indicated for temporary relief of minor aches and pains such as headache, backache, toothache, menstrual cramps, muscle aches, or arthritis pain[1][2][4]. This product is available over-the-counter in several countries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + ibuprofen.